BIO-TECHNE Corp — Director's Dealing 2023

Oct 30, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-10-26

Reporting Person: KEEGAN JOSEPH D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-26	Common Stock	A	1625	—	Acquired	12309	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-26	Stock Options (Right to Buy)	$61.51	A	3937	Acquired	2033-10-26	Common Stock (3937)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$31.26	2027-10-26	Common Stock (12500)	12500	Direct
Stock Options (Right to Buy)	$44.96	2028-10-25	Common Stock (7592)	7592	Direct
Stock Options (Right to Buy)	$50.41	2029-10-24	Common Stock (8044)	8044	Direct
Stock Options (Right to Buy)	$63.92	2030-10-29	Common Stock (6028)	6028	Direct
Stock Options (Right to Buy)	$128.81	2031-10-28	Common Stock (2532)	2532	Direct
Stock Options (Right to Buy)	$73.94	2032-10-27	Common Stock (3460)	3460	Direct

Footnotes

F1: This option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders.